International Journal of Molecular Sciences
Engineered Microorganisms as GLP-1-Oriented Living Therapeutics for Diabetes and Obesity: Mechanisms and Translational Challenges
ReviewDiabetes mellitus
Papers on GLP-1 secretion
42 papers4 new in 30 days
Monday, November 9
Sunday, November 1
Thursday, October 29
Tuesday, October 27
Thursday, September 17
Archives of Physiology and Biochemistry
Precise resistance training alleviates osteosarcopenia via the GLP-1/myostatin path: a 32-week randomized controlled trial and molecular mechanism study
Randomized trial in 98 peopleResistance training
Journal of Microbiology and Biotechnology
Effects of Wilac D001 (Weissella confusa WIKIM51) Supplementation on Metabolic Parameters and Central Adiposity in Overweight Adults: A 12-Week Randomized, Double-Blind, Placebo-Controlled Trial
Randomized trial in peopleOverweight
Thursday, July 30
Frontiers in Endocrinology
Dietary fibers to boost endogenous GLP-1 secretion and satiety: a scoping review
Systematic review of randomized trialsInterventions
Wednesday, June 3
Frontiers in Microbiology
From "spleen governing muscle" to gut microbiota: mechanisms of sarcopenic obesity in perimenopausal women
Systematic reviewMicrobiome composition
Thursday, April 23
Saturday, March 28
International Journal of Molecular Sciences
GLP-1 Receptor Agonists at the Crossroads of Circadian Biology, Sleep, and Metabolic Disease
ReviewGLP-1 receptor agonists
Tuesday, March 17
Thursday, March 12
Wednesday, March 4
American Journal of Physiology Endocrinology and Metabolism
Acute interleukin-1β antagonism decreases systemic inflammation, increases GLP-1 release, and modulates insulin secretion in individuals with prediabetes
Randomized trial in peoplePrediabetes
Friday, February 27
Friday, February 20
Wednesday, February 18
British Journal of Clinical Pharmacology
GLP-1 agonists and the gut microbiome: A bidirectional relationship
ReviewGLP-1 receptor agonists
Friday, February 13
Thursday, February 12
Friday, January 30
Journal of Diabetes and Metabolic Disorders
Bidirectional interplay between the gut microbiota and GLP-1 receptor agonists: towards Microbiome-Mediated therapeutics in type 2 diabetes mellitus
ReviewGLP-1 receptor agonists
Wednesday, January 28
The Journal of Clinical Endocrinology and Metabolism
Exenatide induces an enhanced endogenous glucagon-like peptide-1 secretory response in patients receiving basal insulin
Randomized trial in peopleExenatide
Wednesday, January 21
Frontiers in Endocrinology
Research progress in precision medicine for type 2 diabetes based on the GLP-1
Systematic reviewType 2 diabetes
Monday, December 22
Wednesday, December 10
Obesity Research & Clinical Practice
Ectopic fat deposition in intestinal wall caused the increase of L cell pyroptosis mainly through local hypoxia
Experiments in micePyroptosis
Tuesday, August 19
Microbiological Research
Akkermansia muciniphila: A key player in gut microbiota-based disease modulation
ReviewAkkermansia muciniphila
Tuesday, March 18
Cell Reports Medicine
Bioengineering the metabolic network of CAR T cells with GLP-1 and Urolithin A increases persistence and long-term anti-tumor activity
Experiments in animalsUrolithin A
Sunday, December 22
Wednesday, November 13
Frontiers in Endocrinology
Profiling bitter taste receptors (TAS2R) along the gastrointestinal tract and their influence on enterohormone secretion. Gender- and age-related effects in the colon
Cohort study in peopleGut and microbiome
Monday, April 15
Frontiers in Pharmacology
Understanding the action mechanisms of metformin in the gastrointestinal tract
ReviewMetformin